Revocation and infringement actions involving a cholesterol treatment, prosthetic valves, and methods for analyte detection are among the first to land at the court within its first month, explain Joanne Welch and Darren Smyth of EIP.
- Will de-extinct animals be patent eligible in the US? 05-01-2023
- Gene-editing bill: encouraging innovation or adding complexity? 26-05-2022
- When alliances fail, is arbitration the answer? 24-02-2022
- Growing pains 03-08-2021
- CRISPR: A licence to heal 01-10-2019
Latest genetics news
Decision marks first announcement by the UPC of an injunction in open court | Ruling in Munich Local Division forecast to have far-reaching consequences for defendant| Comment from 10x vice president of IP and litigation, Randy Wu.